429 related articles for article (PubMed ID: 28395217)
1. Novel alkylated azoles as potent antifungals.
Shrestha SK; Garzan A; Garneau-Tsodikova S
Eur J Med Chem; 2017 Jun; 133():309-318. PubMed ID: 28395217
[TBL] [Abstract][Full Text] [Related]
2. Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.
Thamban Chandrika N; Shrestha SK; Ngo HX; Tsodikov OV; Howard KC; Garneau-Tsodikova S
J Med Chem; 2018 Jan; 61(1):158-173. PubMed ID: 29256601
[TBL] [Abstract][Full Text] [Related]
3. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
[TBL] [Abstract][Full Text] [Related]
4. Novel fluconazole derivatives with promising antifungal activity.
Thamban Chandrika N; Shrestha SK; Ngo HX; Howard KC; Garneau-Tsodikova S
Bioorg Med Chem; 2018 Feb; 26(3):573-580. PubMed ID: 29279242
[TBL] [Abstract][Full Text] [Related]
5. New azoles with potent antifungal activity: design, synthesis and molecular docking.
Che X; Sheng C; Wang W; Cao Y; Xu Y; Ji H; Dong G; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2009 Oct; 44(10):4218-26. PubMed ID: 19539408
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of resistance to azole antifungals.
Lupetti A; Danesi R; Campa M; Del Tacca M; Kelly S
Trends Mol Med; 2002 Feb; 8(2):76-81. PubMed ID: 11815273
[TBL] [Abstract][Full Text] [Related]
7. New azoles with antifungal activity: Design, synthesis, and molecular docking.
Chai X; Zhang J; Cao Y; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
Bioorg Med Chem Lett; 2011 Jan; 21(2):686-9. PubMed ID: 21190856
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
[TBL] [Abstract][Full Text] [Related]
9. New miconazole-based azoles derived from eugenol show activity against Candida spp. and Cryptococcus gattii by inhibiting the fungal ergosterol biosynthesis.
Campos Péret VA; Reis RCFM; Braga SFP; Benedetti MD; Caldas IS; Carvalho DT; Santana LFA; Johann S; Souza TB
Eur J Med Chem; 2023 Aug; 256():115436. PubMed ID: 37146343
[TBL] [Abstract][Full Text] [Related]
10. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.
Emami S; Foroumadi A; Falahati M; Lotfali E; Rajabalian S; Ebrahimi SA; Farahyar S; Shafiee A
Bioorg Med Chem Lett; 2008 Jan; 18(1):141-6. PubMed ID: 18032039
[TBL] [Abstract][Full Text] [Related]
11. Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Yu PK; Moron-Espiritu LS; Lao AR
mSystems; 2022 Dec; 7(6):e0069122. PubMed ID: 36383015
[TBL] [Abstract][Full Text] [Related]
12. Combating fluconazole-resistant fungi with novel β-azole-phenylacetone derivatives.
Zhao L; Sun N; Tian L; Sun Y; Chen Y; Wang X; Zhao S; Su X; Zhao D; Cheng M
Eur J Med Chem; 2019 Dec; 183():111689. PubMed ID: 31541871
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296
[TBL] [Abstract][Full Text] [Related]
14. A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.
Hof H
Mycoses; 2006; 49 Suppl 1():2-6. PubMed ID: 16961575
[TBL] [Abstract][Full Text] [Related]
15. Azole derivatives with naphthalene showing potent antifungal effects against planktonic and biofilm forms of Candida spp.: an in vitro and in silico study.
Sari S; Koçak E; Kart D; Özdemir Z; Acar MF; Sayoğlu B; Karakurt A; Dalkara S
Int Microbiol; 2021 Jan; 24(1):93-102. PubMed ID: 32889579
[TBL] [Abstract][Full Text] [Related]
16. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies.
Doğan İS; Saraç S; Sari S; Kart D; Eşsiz Gökhan Ş; Vural İ; Dalkara S
Eur J Med Chem; 2017 Apr; 130():124-138. PubMed ID: 28242548
[TBL] [Abstract][Full Text] [Related]
17. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
18. Medically important fungi respond to azole drugs: an update.
Zavrel M; White TC
Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
[TBL] [Abstract][Full Text] [Related]
19. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
[TBL] [Abstract][Full Text] [Related]
20. Discovery of highly potent novel antifungal azoles by structure-based rational design.
Wang W; Sheng C; Che X; Ji H; Cao Y; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2009 Oct; 19(20):5965-9. PubMed ID: 19748782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
